Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01406 |
| Species: | Homo sapiens |
| Position : | chr10:5419501-5420500 |
| Year: | 2019 |
| Title: | Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast carcinoma |
| PMID: | 31594934 |
| MONDO: | MONDO:0006120 |
| Tissue: | Breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | MCF7 Breast Cancer |
| CVCL ID: | CVCL_0031 |
| Cell Type: | breast carcinoma cell |
| Cell Ontology ID: | CL:0000646 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq, ChIP-seq, Hi-C, ChIA-PET, GRO-seq |
| Low Throughput Method: | CRISPR Activation (CRISPRa), LNA-Mediated Knockdown, RT-RT-qPCR, Cell Proliferation Assay |
| Target gene : | NET1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|